Cargando…

The ITGB6 gene: its role in experimental and clinical biology

Integrin αvβ6 is a membrane-spanning heterodimeric glycoprotein involved in wound healing and the pathogenesis of diseases including fibrosis and cancer. Therefore, it is of great clinical interest for us to understand the molecular mechanisms of its biology. As the limiting binding partner in the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Meecham, Amelia, Marshall, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285966/
https://www.ncbi.nlm.nih.gov/pubmed/32550552
http://dx.doi.org/10.1016/j.gene.2019.100023
_version_ 1783544796582772736
author Meecham, Amelia
Marshall, John F
author_facet Meecham, Amelia
Marshall, John F
author_sort Meecham, Amelia
collection PubMed
description Integrin αvβ6 is a membrane-spanning heterodimeric glycoprotein involved in wound healing and the pathogenesis of diseases including fibrosis and cancer. Therefore, it is of great clinical interest for us to understand the molecular mechanisms of its biology. As the limiting binding partner in the heterodimer, the β6 subunit controls αvβ6 expression and availability. Here we describe our understanding of the ITGB6 gene encoding the β6 subunit, including its structure, transcriptional and post-transcriptional regulation, the biological effects observed in ITGB6 deficient mice and clinical cases of ITGB6 mutations.
format Online
Article
Text
id pubmed-7285966
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72859662020-06-16 The ITGB6 gene: its role in experimental and clinical biology Meecham, Amelia Marshall, John F Gene X Article Integrin αvβ6 is a membrane-spanning heterodimeric glycoprotein involved in wound healing and the pathogenesis of diseases including fibrosis and cancer. Therefore, it is of great clinical interest for us to understand the molecular mechanisms of its biology. As the limiting binding partner in the heterodimer, the β6 subunit controls αvβ6 expression and availability. Here we describe our understanding of the ITGB6 gene encoding the β6 subunit, including its structure, transcriptional and post-transcriptional regulation, the biological effects observed in ITGB6 deficient mice and clinical cases of ITGB6 mutations. Elsevier 2019-11-06 /pmc/articles/PMC7285966/ /pubmed/32550552 http://dx.doi.org/10.1016/j.gene.2019.100023 Text en © 2019 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Meecham, Amelia
Marshall, John F
The ITGB6 gene: its role in experimental and clinical biology
title The ITGB6 gene: its role in experimental and clinical biology
title_full The ITGB6 gene: its role in experimental and clinical biology
title_fullStr The ITGB6 gene: its role in experimental and clinical biology
title_full_unstemmed The ITGB6 gene: its role in experimental and clinical biology
title_short The ITGB6 gene: its role in experimental and clinical biology
title_sort itgb6 gene: its role in experimental and clinical biology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285966/
https://www.ncbi.nlm.nih.gov/pubmed/32550552
http://dx.doi.org/10.1016/j.gene.2019.100023
work_keys_str_mv AT meechamamelia theitgb6geneitsroleinexperimentalandclinicalbiology
AT marshalljohnf theitgb6geneitsroleinexperimentalandclinicalbiology
AT meechamamelia itgb6geneitsroleinexperimentalandclinicalbiology
AT marshalljohnf itgb6geneitsroleinexperimentalandclinicalbiology